Citation: Hl. Minhas et Plf. Giangrande, Presentation of severe haemophilia - A role for accident and emergency doctors?, EMERG MED J, 18(4), 2001, pp. 246-249
Citation: K. Sukhu et al., Variation in inhibitor reactivity in acquired haemophilia A with differentconcentrates, CLIN LAB H, 22(5), 2000, pp. 287-290
Authors:
Sukhu, K
Martin, PG
Cross, L
Keeling, DM
Giangrande, PLF
Citation: K. Sukhu et al., Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest (R) vWF) automated on the MDA (R)-180 coagulometer, CLIN LAB H, 22(1), 2000, pp. 29-32
Authors:
Asselta, R
Duga, S
Simonic, T
Malcovati, M
Santagostino, E
Giangrande, PLF
Mannucci, PM
Tenchini, ML
Citation: R. Asselta et al., Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation, BLOOD, 96(7), 2000, pp. 2496-2500
Authors:
Martin, PG
Sukhu, K
Chambers, E
Giangrande, PLF
Citation: Pg. Martin et al., Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs, CLIN LAB H, 21(2), 1999, pp. 125-128
Authors:
Wilde, JT
Lee, CA
Collins, P
Giangrande, PLF
Winter, M
Shiach, CR
Citation: Jt. Wilde et al., Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders, BR J HAEM, 107(3), 1999, pp. 556-559